Karen Rigat

895 total citations
13 papers, 511 citations indexed

About

Karen Rigat is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Karen Rigat has authored 13 papers receiving a total of 511 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hepatology, 9 papers in Epidemiology and 8 papers in Infectious Diseases. Recurrent topics in Karen Rigat's work include Hepatitis C virus research (12 papers), Hepatitis B Virus Studies (8 papers) and HIV/AIDS drug development and treatment (8 papers). Karen Rigat is often cited by papers focused on Hepatitis C virus research (12 papers), Hepatitis B Virus Studies (8 papers) and HIV/AIDS drug development and treatment (8 papers). Karen Rigat collaborates with scholars based in United States, Germany and France. Karen Rigat's co-authors include Julie A. Lemm, Richard J. Colonno, Guangxiang Luo, Robert Hamatake, Susan B. Roberts, Ying-Kai Wang, Jin-Hua Sun, Donald R. O’Boyle, Peter T. Nower and Lourdes Valera and has published in prestigious journals such as Journal of Biological Chemistry, Analytical Biochemistry and Journal of Virology.

In The Last Decade

Karen Rigat

13 papers receiving 492 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karen Rigat United States 10 363 262 193 115 66 13 511
Darius Bilimoria Canada 10 320 0.9× 171 0.7× 220 1.1× 161 1.4× 55 0.8× 11 472
Hyunsoon Kang United States 9 649 1.8× 495 1.9× 451 2.3× 173 1.5× 33 0.5× 11 795
Robert J. Carrick United States 13 459 1.3× 524 2.0× 186 1.0× 128 1.1× 52 0.8× 14 806
Angela Skelton United States 13 492 1.4× 421 1.6× 373 1.9× 121 1.1× 158 2.4× 20 754
Stefania Lostia United States 9 278 0.8× 270 1.0× 461 2.4× 239 2.1× 33 0.5× 11 665
Lotte Coelmont Belgium 9 293 0.8× 219 0.8× 154 0.8× 187 1.6× 35 0.5× 19 494
Anna Boguszewska‐Chachulska Poland 11 121 0.3× 98 0.4× 99 0.5× 148 1.3× 34 0.5× 26 369
Ona Barauskas United States 9 154 0.4× 183 0.7× 244 1.3× 142 1.2× 75 1.1× 15 513
Margaret Gartland United States 9 148 0.4× 156 0.6× 201 1.0× 82 0.7× 19 0.3× 15 404
Kristina Prachanronarong United States 9 89 0.2× 106 0.4× 150 0.8× 126 1.1× 9 0.1× 11 329

Countries citing papers authored by Karen Rigat

Since Specialization
Citations

This map shows the geographic impact of Karen Rigat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Rigat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Rigat more than expected).

Fields of papers citing papers by Karen Rigat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen Rigat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Rigat. The network helps show where Karen Rigat may publish in the future.

Co-authorship network of co-authors of Karen Rigat

This figure shows the co-authorship network connecting the top 25 collaborators of Karen Rigat. A scholar is included among the top collaborators of Karen Rigat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Rigat. Karen Rigat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
2.
Rigat, Karen, Hao Lu, Ying-Kai Wang, et al.. (2014). Mechanism of Inhibition for BMS-791325, a Novel Non-nucleoside Inhibitor of Hepatitis C Virus NS5B Polymerase. Journal of Biological Chemistry. 289(48). 33456–33468. 17 indexed citations
3.
Wang, Chunfu, Lingling Jia, Donald R. O’Boyle, et al.. (2014). Comparison of Daclatasvir Resistance Barriers on NS5A from Hepatitis C Virus Genotypes 1 to 6: Implications for Cross-Genotype Activity. Antimicrobial Agents and Chemotherapy. 58(9). 5155–5163. 54 indexed citations
4.
Lemm, Julie A., Mengping Liu, Robert G. Gentles, et al.. (2014). Preclinical Characterization of BMS-791325, an Allosteric Inhibitor of Hepatitis C Virus NS5B Polymerase. Antimicrobial Agents and Chemotherapy. 58(6). 3485–3495. 47 indexed citations
5.
Ding, Min, Feng He, Thomas W. Hudyma, et al.. (2012). Synthesis and SAR studies of novel heteroaryl fused tetracyclic indole-diamide compounds: Potent allosteric inhibitors of the hepatitis C virus NS5B polymerase. Bioorganic & Medicinal Chemistry Letters. 22(8). 2866–2871. 15 indexed citations
6.
7.
Gentles, Robert G., S. Sheriff, Brett R. Beno, et al.. (2011). Investigation of the mode of binding of a novel series of N-benzyl-4-heteroaryl-1-(phenylsulfonyl)piperazine-2-carboxamides to the hepatitis C virus polymerase. Bioorganic & Medicinal Chemistry Letters. 21(8). 2212–2215. 8 indexed citations
8.
Martin, Scott, Peter W. Glunz, Brett R. Beno, et al.. (2011). The Synthesis and evaluation of a novel class of (E)-3-(1-cyclohexyl-1H-pyrazol-3-yl)-2-methylacrylic acid Hepatitis C virus polymerase NS5B inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(10). 2869–2872. 11 indexed citations
9.
Rigat, Karen, Yi Wang, Thomas W. Hudyma, et al.. (2010). Ligand-induced changes in hepatitis C virus NS5B polymerase structure. Antiviral Research. 88(2). 197–206. 24 indexed citations
10.
Wang, Ying-Kai, Karen Rigat, Jin-Hua Sun, Min Gao, & Susan B. Roberts. (2007). RNA template-mediated inhibition of hepatitis C virus RNA-dependent RNA polymerase activity. Archives of Biochemistry and Biophysics. 470(2). 146–152. 7 indexed citations
11.
Wang, Ying-Kai, Karen Rigat, Susan B. Roberts, & Min Gao. (2006). A homogeneous, solid-phase assay for hepatitis C virus RNA-dependent RNA polymerase. Analytical Biochemistry. 359(1). 106–111. 16 indexed citations
12.
O’Boyle, Donald R., Peter T. Nower, Julie A. Lemm, et al.. (2005). Development of a Cell-Based High-Throughput Specificity Screen Using a Hepatitis C Virus-Bovine Viral Diarrhea Virus Dual Replicon Assay. Antimicrobial Agents and Chemotherapy. 49(4). 1346–1353. 53 indexed citations
13.
Luo, Guangxiang, et al.. (2000). De Novo Initiation of RNA Synthesis by the RNA-Dependent RNA Polymerase (NS5B) of Hepatitis C Virus. Journal of Virology. 74(2). 851–863. 232 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Darius Bilimoria Breakdown of academic impact, for papers by Hyunsoon Kang Breakdown of academic impact, for papers by Robert J. Carrick Breakdown of academic impact, for papers by Angela Skelton Breakdown of academic impact, for papers by Stefania Lostia Breakdown of academic impact, for papers by Lotte Coelmont Breakdown of academic impact, for papers by Anna Boguszewska‐Chachulska Breakdown of academic impact, for papers by Ona Barauskas Breakdown of academic impact, for papers by Margaret Gartland Breakdown of academic impact, for papers by Kristina Prachanronarong
Rankless by CCL
2026